Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT05540821
Other study ID # 20223357017
Secondary ID
Status Recruiting
Phase
First received
Last updated
Start date June 1, 2022
Est. completion date June 30, 2025

Study information

Verified date September 2022
Source Shenzhen Second People's Hospital
Contact Qiuxiang Chen
Phone 0755-83366388-8856
Email 616441594@qq.com
Is FDA regulated No
Health authority
Study type Observational [Patient Registry]

Clinical Trial Summary

Endometriosis occurs in about 10-15% of women of childbearing age and is a major cause of infertility and dysmenorrhea. Deep endometriosis is the most serious manifestation of endometriosis, which often affects the quality of life of patients and requires surgical treatment. Detailed description of DE lesions before operation can contribute to treatment planning. However, the detection rate of DE by conventional ultrasound is low, highly dependent on the experience of the examiner and poor reproducibility. Hysterosalpingo-contrast sonography can be used to assess the patency of the fallopian tube but cannot visualize other pelvic structures. Saline-infusion sonoPODography can provide a good acoustic window for pelvic tissue visualization. Therefore, this study is the first to present double contrast-enhanced ultrasound (Hysterosalpingo-contrast sonography and sonoPODography) examination of the pelvic cavity, based on the #Enzian classification system, for preoperative evaluation of DE lesions. The results of laparoscopic surgery were taken as the gold standard to compare the diagnostic efficacy of double contrast-enhanced ultrasound and conventional transvaginal ultrasound in preoperative evaluation of pelvic DE lesions, improving the preoperative diagnosis, reduce the risk of surgery and reduce postoperative recurrence. To compare the diagnostic efficacy of different examination methods in different compartment of DE, and to explore the best examination method suitable for different parts of DE, providing theoretical basis for further early screening and personalized treatment of DE in the future.


Recruitment information / eligibility

Status Recruiting
Enrollment 156
Est. completion date June 30, 2025
Est. primary completion date June 30, 2025
Accepts healthy volunteers No
Gender Female
Age group 18 Years to 45 Years
Eligibility Inclusion Criteria: 1. Female patients diagnosed with adenomyosis and/or chocolate cysts, suspected infertility with endometriosis, and proposed for laparoscopic surgery at our hospital. 2. Sexual life history. 3. Surgery was performed within 2 months of the examination. 4. Subjects volunteered to participate in the study and signed the informed consent form. Exclusion Criteria: 1. colporrhagia. 2. Acute inflammation of reproductive system. 3. Allergic to ultrasound contrast agent (Sonovue). 4. Suspected malignant lesions of cervix or uterine cavity.

Study Design


Related Conditions & MeSH terms


Intervention

Diagnostic Test:
Hysterosalpingo-contrast sonography and sonoPODography
Before operation, phloroglucinol 40mg of antispasmolysis was injected intramuscular, and then cervical dilation was performed according to aseptic operation requirements. A 12G double-lumen catheter was inserted into the uterine cavity, and 1.5-1.8ml of normal saline was injected into the sacculus. Transvaginal 2/3/4D hysterosalpingo-contrast sonography: One operator extracted 2ml of Sonovue and injected 18ml of normal saline through a dual-lumen catheter, and the other operator started the four-dimensional ultrasound mode to collect dynamic volume data. sonoPODography: Sterile saline was injected into the intrauterine cavity, with an upper limit of 20ml. The normal saline flowed from the intrauterine cavity into the pelvic cavity through the bilateral fallopian tubes, forming a good acoustic window. Pelvic observation was then performed.

Locations

Country Name City State
China Shenzhen Second People's Hospital Shenzhen Guangdong

Sponsors (1)

Lead Sponsor Collaborator
Shenzhen Second People's Hospital

Country where clinical trial is conducted

China, 

References & Publications (5)

Exacoustos C, Malzoni M, Di Giovanni A, Lazzeri L, Tosti C, Petraglia F, Zupi E. Ultrasound mapping system for the surgical management of deep infiltrating endometriosis. Fertil Steril. 2014 Jul;102(1):143-150.e2. doi: 10.1016/j.fertnstert.2014.03.043. Epub 2014 Apr 29. — View Citation

Leonardi M, Espada M, Lu C, Stamatopoulos N, Condous G. A Novel Ultrasound Technique Called Saline Infusion SonoPODography to Visualize and Understand the Pouch of Douglas and Posterior Compartment Contents: A Feasibility Study. J Ultrasound Med. 2019 Dec;38(12):3301-3309. doi: 10.1002/jum.15022. Epub 2019 May 15. — View Citation

Nisenblat V, Bossuyt PM, Farquhar C, Johnson N, Hull ML. Imaging modalities for the non-invasive diagnosis of endometriosis. Cochrane Database Syst Rev. 2016 Feb 26;2:CD009591. doi: 10.1002/14651858.CD009591.pub2. Review. — View Citation

Taylor HS, Kotlyar AM, Flores VA. Endometriosis is a chronic systemic disease: clinical challenges and novel innovations. Lancet. 2021 Feb 27;397(10276):839-852. doi: 10.1016/S0140-6736(21)00389-5. Review. — View Citation

Tuttlies F, Keckstein J, Ulrich U, Possover M, Schweppe KW, Wustlich M, Buchweitz O, Greb R, Kandolf O, Mangold R, Masetti W, Neis K, Rauter G, Reeka N, Richter O, Schindler AE, Sillem M, Terruhn V, Tinneberg HR. [ENZIAN-score, a classification of deep infiltrating endometriosis]. Zentralbl Gynakol. 2005 Oct;127(5):275-81. Review. German. — View Citation

Outcome

Type Measure Description Time frame Safety issue
Primary True positive rate According to the #Enzian classification system, the proportion of the number of DE lesions found by double contrast-enhanced ultrasound (DCEUS) in the pelvic cavity to the number of DE lesions found by laparoscopy. Surgery was performed within 2 months of the examination
Primary True negative rate According to the #Enzian classification system, the proportion of pelvic normal numbers shown by DCEUS to the number of pelvic normal numbers show by laparoscopy. Surgery was performed within 2 months of the examination
Primary False negative rate According to the #Enzian classification system, the proportion of pelvic DE lesions that were not detected by DCEUS in pelvic DE lesions. Surgery was performed within 2 months of the examination
Primary False positive rate According to the #Enzian classification system, in the non-pelvic DE lesions, the proportion of the number of DE lesions diagnosed by pelvic dual contrast-enhanced ultrasound accounted for. Surgery was performed within 2 months of the examination
See also
  Status Clinical Trial Phase
Recruiting NCT05179109 - Robotic Versus Laparoscopic Surgery for Deep Endometriosis N/A
Recruiting NCT06386276 - Surgical TReatment of Women With Deep ENDometriosis
Completed NCT05239871 - Indirect Ultrasonographic Findings for Parametrial Involvement in Deep Endometriosis
Recruiting NCT05570786 - Subdermal Implant-bioabsorbable Gestrinone Pellet for Endometriosis Pelvic Pain Treatment Phase 2
Completed NCT03779256 - Bowel ENDOmetriosis; Evaluation of Diagnostics and Quality of Life
Recruiting NCT06286371 - Pelvic Neuro-Angiogenesis in Deep Endometriosis N/A
Completed NCT04669769 - Retrospective Analysis of Results of Surgery for Deep Bowel Endometriosis
Recruiting NCT03080558 - Estimation of Vascularization After Treatment of Deep Rectovaginal Endometriosis Node by Rectal Shaving Phase 4
Recruiting NCT04610710 - Impact of Operation on Fertility for Women With Severe Endometriosis N/A
Withdrawn NCT01949597 - Recurrences After Surgery for Deep Endometriosis Depending on the Involvement of the Surgical Margins in the Specimen
Recruiting NCT03204682 - Repetitive Transcranial Magnetic Stimulation as an Analgesic Treatment in Endometriosis Chronic Pain : Feasibility N/A
Recruiting NCT05291624 - Ultrasonographic and Surgical Assessment of Endometriosis by AAGL 2021 Endometriosis Classification